Effects of P-glycoprotein and its inhibitors on apoptosis in K562 cells

Molecules

Volumn 19, Issue 9, 2014, Pages 13061-13075

  Zu, Yaqiong ^a   Yang, Zhiyong ^b   Tang, Songshan ^c   Han, Ying ^a   Ma, Jun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HUYA Bioscience International LLC   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; H108; K562 cells; P glycoprotein; P glycoprotein inhibitors; PSC833; Verapamil

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLOSPORIN DERIVATIVE; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; VALSPODAR; VERAPAMIL;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; DRUG EFFECTS; DRUG RESISTANCE; FLOW CYTOMETRY; GENETICS; HUMAN; K562 CELL LINE; METABOLISM; MULTIDRUG RESISTANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL CYCLE CHECKPOINTS; CYCLOSPORINS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; K562 CELLS; P-GLYCOPROTEIN; VERAPAMIL;

EID: 84908287627     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190913061     Document Type: Article

References (36)

1. Pérez-Tomás, R. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment. Curr. Med. Chem. 2006, 13, 1859-1876.
2. Sharom, F.J. The P-glycoprotein multidrug transporter. Essays Biochem. 2011, 50, 161-178.
3. Binkhathlan, Z.; Lavasanifar, A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer Current status and future perspectives. Curr. Cancer Drug Targets 2013, 13, 326-346.
4. Wang, L.; Meng, Q.; Wang, C.; Liu, Q.; Peng, J.; Huo, X.; Sun, H.; Ma, X.; Liu, K. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition. J. Nat. Prod. 2013, 76, 909-914.
5. Shen, F.; Chu, S.; Bence, AK.; Bailey, B.; Xue, X.; Erickson, PA.; Montrose, MH.; Beck, W.T.; Erickson, L.C. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J. Pharmacol. Exp. Ther. 2008, 324, 95-102.
6. Hannun, Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997, 89, 1845-1853.
7. Russo, A.; Terrasi, M.; Agnese, V.; Santini, D.; Bazan, V. Apoptosis a relevant tool for anticancer therapy. Ann. Oncol. 2006, 17, 115-123.
8. Ganguly, A.; Basu, S.; Banerjee, K.; Chakraborty, P.; Sarkar, A.; Chatterjee, M.; Chaudhuri, S.K. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis. Mol. Biosyst. 2011, 7, 1701-1712.
9. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M.M.; Pastan, I.; Willingham, M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 1987, 84, 7735-7738.
10. Gupta, S.; Gollapudi, S. P-glycoprotein (MDR 1 gene product) in cells of the immune system. Its possible physiologic role and alteration in aging and human immunodeficiency virus-1 (HIV-1) infection. J. Clin. Immunol. 1993, 13, 289-301.
11. Myllynen, P.; Kummu, M.; Sieppi, E. ABCB1 and ABCG2 expression in the placenta and fetus: An interspecies comparison. Expert Opin. Drug Metab. Toxicol. 2010, 6, 1385-1398.
12. Mizutani, T.; Masuda, M.; Nakai, E.; Furumiya, K.; Togawa, H.; Nakamura, Y.; Kawai, Y.; Nakahira, K.; Shinkai, S.; Takahashi, K. Genuine functions of P-glycoprotein (ABCB1). Curr. Drug. Metab. 2008, 9, 167-174.
13. Sui, H.; Fan, Z.Z.; Li, Q. Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells. J. Int. Med. Res. 2012, 40, 426-435.
14. Viale, M.; Cordazzo, C.; de Totero, D.; Budriesi, R.; Rosano, C.; Leoni, A.; Ioan, P.; Aiello, C.; Croce, M.; Andreani, A.; et al. Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis. Investig. New Drugs 2011, 29, 98-109.
15. Pallis, M.; Russell, N. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. Blood 2000, 95, 2897-2904.
16. Turella, P.; Filomeni, G.; Dupuis, M.L.; Ciriolo, M.R.; Molinari, A.; de Maria, F.; Tombesi, M.; Cianfriglia, M.; Federici, G.; Ricci, G.; et al. A strong glutathione S-transferase inhibitor overcomes the P-glycoprotein-mediated resistance in tumor cells. 6-(7-Nitro-2, 1, 3-benzoxadiazol-4-ylthio) hexanol (NBDHEX) triggers a caspase-dependent apoptosis in MDR1-expressing leukemia cells. J. Biol. Chem. 2006, 281, 23725-23732.
17. Ruefli, A.A.; Smyth, M.J.; Johnstone, R.W. HMBA induces activation of a caspase-independent cell death pathwayto overcome P-glycoprotein-mediated multidrug resistance. Blood 2000, 95, 2378-2385.
18. Wu, Q.L.; Wu, X.P.; Liang, Y.J.; Chen, L.M.; Ding, Y.; Fu, L.W. P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells. World J. Gastroenterol. 2005, 11, 3544-3548.
19. Saraswathy, M.; Gong, S. Different strategies to overcome multidrug resistance in cancer. Biotechnol. Adv. 2013, 31, 1397-1407.
20. Darby, R.A.; Callaghan, R.; McMahon, R.M. P-glycoprotein inhibition the past, the present and the future. Curr. Drug Metab. 2011, 12, 722-731.
21. White, Y.; Hamada, T.; Yoshimitsu, M.; Nakashima, M.; Hachiman, M.; Kozako, T.; Matsushita, K.; Uozumi, K.; Suzuki, S.; Kofune, H.; et al. Novel cytotoxic isolated from Jamaican Hyptisverticillatajacq induces apoptosis and overcomes multidrug resistance. Anticancer Res. 2011, 31, 4251-4257.
22. Robinson, L.J.; Roberts, W.K.; Ling, T.T.; Lamming, D.; Sternberg, S.S.; Roepe, P.D. Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 1997, 36, 11169-11178.
23. Fantappiè, O.; Solazzo, M.; Lasagna, N.; Platini, F.; Tessitore, L.; Mazzanti, R. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res. 2007, 67, 4915-4923.
24. Karwatsky, J.; Lincoln, M.C.; Georges, E. A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity. Biochemistry 2003, 42, 12163-12173.
25. Riedl, S.J.; Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 2004, 5, 897-907.
26. Hensley, P.; Mishra, M.; Kyprianou, N. Targeting caspases in cancer therapeutics. Biol. Chem. 2013, 394, 831-843.
27. Mazumder, S.; Plesca, D.; Almasan, A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol. Biol. 2008, 414, 13-21.
28. Kim, TH.; Shin, Y.J.; Won, A.J.; Lee, B.M.; Choi, W.S.; Jung, J.H.; Chung, H.Y.; Kim, H.S. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochim. Biophys. Acta 2013, 1840, 615-625.
29. O'Brien, M.M.; Lacayo, N.J.; Lum, B.L.; Kshirsagar, S.; Buck, S.; Ravindranath, Y.; Bernstein, M.; Weinstein, H.; Chang, M.N.; Arceci, R.J.; et al. Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia. A report from the Children's Oncology Group. Pediatr. Blood Cancer 2010, 54, 694-702.
30. Yusa, K.; Tsuruo, T. Reversal mechanism of multidrug resistance by verapamil. Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 1989, 49, 5002-5006.
31. Yang, Z.Y.; Liu, G.Q.; Huang, W.L. Effects of novel tetrahydroisoquinoline derivative H108 on activity of P-glycoprotein vitro and injury of PC12 cells. Chin. J. Clin. Pharmacol. Ther. 2004, 9, 275-280.
32. Zhang, M.H.; Hu, Y.D.; Xu, Y.; Xiao, Y.; Luo, Y.; Song, Z.C.; Zhou, J. Human mesenchymal stem cells enhance autophagy of lung carcinoma cells against apoptosis during serum deprivation. Int. J. Oncol. 2013, 42, 1390-1398.
33. Smyth, M.J.; Krasovskis, E.; Sutton, V.R.; Johnstone, R.W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc. Natl. Acad. Sci. USA 1998, 95, 7024-7029.
34. Johnstone, R.W.; Cretney, E.; Smyth, M.J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 1999, 93, 1075-1085.
35. Gibalová, L.; Sereš, M.; Rusnák, A.; Ditte, P.; Labudová, M.; Uhrík, B.; Pastorek, J.; Sedlák, J.; Breier, A.; Sulová, Z. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Toxicol. In Vitro 2012, 26, 435-444.
36. Rumjanek, V.M.; Trindade, G.S.; Wagner-Souza, K.; de-Oliveira, M.C.; Marques-Santos, L.F.; Maia, R.C.; Capella, M.A. Multidrug resistance in tumour cells. Characterization of the multidrug resistant cell line K562-Lucena 1. An. Acad. Bras. Ciênc. 2001, 73, 57-69.